
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (Germany), Germany, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
45%
Total
Publications
91
Total Open
Publications
41
Total
Citations
3.2K
Open Access
Percentage
45%
Total
Publications
91
Total Open
Publications
41
Total
Citations
3.2K
Breakdown
Publisher Open
23%
Both
20%
Other Platform Open
3%
Closed
54%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
19
Hybrid 10%
4
No Guarantees 42%
17
Other Platform Open
Domain 82%
18
Institution 64%
14
Other Internet 14%
3
Preprint 5%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 18 |
doaj.org OAI-PMH Repository | Institution | 10 |
University of Groningen | Institution | 2 |
DOI | Other Internet | 2 |
Unknown Repository | Other Internet | 1 |
University of Zurich | Institution | 1 |
RWTH Aachen University | Institution | 1 |
Robert Gordon University | Institution | 1 |
Research Square | Preprint | 1 |
Maastricht University | Institution | 1 |